Make Better Decisions

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
Chinese Patent Office
Queensland Health

Generated: December 15, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 206392

« Back to Dashboard

NDA 206392 describes ASPIRIN AND DIPYRIDAMOLE, which is a drug marketed by Amneal Pharms, Barr, Impax Labs Inc, Par Pharm Inc, Sandoz Inc, and Zydus Pharms Usa Inc, and is included in six NDAs. It is available from five suppliers. Additional details are available on the ASPIRIN AND DIPYRIDAMOLE profile page.

The generic ingredient in ASPIRIN AND DIPYRIDAMOLE is aspirin; dipyridamole. There are twenty-one drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the aspirin; dipyridamole profile page.

Summary for 206392

Therapeutic Class:Blood Products/Modifiers/ Volume Expanders
Formulation / Manufacturing:see details

Suppliers and Packaging for NDA: 206392

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ASPIRIN AND DIPYRIDAMOLE aspirin; dipyridamole CAPSULE, EXTENDED RELEASE;ORAL 206392 ANDA AvKARE, Inc. 42291-116 42291-116-60 60 CAPSULE in 1 BOTTLE (42291-116-60)
ASPIRIN AND DIPYRIDAMOLE aspirin; dipyridamole CAPSULE, EXTENDED RELEASE;ORAL 206392 ANDA American Health Packaging 60687-305 60687-305-32 20 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-305-32) > 1 CAPSULE in 1 BLISTER PACK (60687-305-33)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:CAPSULE, EXTENDED RELEASE;ORALStrength25MG;200MG
Approval Date:Mar 8, 2016TE:ABRLD:No

Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
Daiichi Sankyo
Johnson and Johnson
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch: